Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04272723

Acronym

Observ-MTEV

Enrollment

383

Registered

2020-02-17

Start date

2019-08-21

Completion date

2023-07-01

Last updated

2023-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anticoagulant, Deep Vein Thrombosis, Pulmonary Embolism, Survey, Venous Thromboembolism

Keywords

Survey, Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism, Anticoagulant, Clinical Practice, Therapeutic management

Brief summary

In France, venous thromboembolic (VTE) disease is usually managed by vascular medicine physicians (VMP). The national OPTIMEV study, conducted more than 12 years ago among VMP practicing in hospital and in the community described the management of VTE in routine clinical practice. Since then a large number of practice changing studies have been published. This includes trials that have validated the use of direct oral anticoagulants (DOAC), the new standard of care of VTE, as per new national and international guidelines. Management of VTE in 2019 appears to be significantly different from the one that prevailed more than 10 years ago when the last national survey was conducted. It is therefore important to have an update on the routine clinical practice management of VTE by VMP. In this perspective the investigators aim to conduct a national survey among VMP practicing in France

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* vascular medicine physicians who are active members of the SFMV (French Society of Vascular Medicine) * vascular medicine physicians registered as willing to do medical research

Exclusion criteria

* vascular medicine physicians who refuse to provide consent * vascular medicine physicians who are retired * non-practicing vascular medicine physicians

Design outcomes

Primary

Measure	Time frame	Description
Inter-practician variability of clinical care of venous thromboembolic in routine clinical practice	up to 3 months after inclusion	The variation in venous thromboembolic management in routine clinical practice is assessed by analysing the management of the 5 consecutive acute venous thromboembolic patients reported by each participating physician

Secondary

Measure	Time frame	Description
Inter-practician variability of clinical care of venous thromboembolic according to patient age	up to 6 months after inclusion	patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk
Inter-practician variability of clinical care of venous thromboembolic according to patient body weight	up to 6 months after inclusion	patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk
Inter-practician variability of clinical care of venous thromboembolic according to patient bleeding risk	up to 6 months after inclusion	patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk

Countries

France

Outcome results